Randomized phase III study of high-dose chemotherapy (hdc) with autologous stem cell support as consolidation in high-risk postoperative breast cancer: japan clinical oncology group (JCOG9208). - Tokuda,Y.; Tajima,T.; Narabayashi,M. (Proc Am Soc Clin Oncol, 2001)